Harpoon Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Harpoon Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 35% to $31,915,000. The net income raised on -$67,137,000 and profit margin reached -210%. Total operating expenses were $100,240,000.
Profit Margin
| 2016 | 0 | -11.40M | |
|---|---|---|---|
| 2017 | 708K | -16.83M | -2377.12% |
| 2018 | 4.75M | -27.36M | -576.13% |
| 2019 | 5.77M | -51.99M | -900.05% |
| 2020 | 17.44M | -46.37M | -265.86% |
| 2021 | 23.65M | -166.43M | -703.62% |
| 2022 | 31.91M | -67.13M | -210.36% |
HARP Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 31.91M | 23.65M | 17.44M | 5.77M | 4.75M | 708K | 0 |
Cost of revenue | 3.09M | 2.64M | 0 | 0 | 0 | 0 | 0 |
Gross profit | 28.81M | 21.00M | 17.44M | 5.77M | 4.75M | 708K | 0 |
Operating exp. | |||||||
Research and development | 81.39M | 72.12M | 52.56M | 41.59M | 26.36M | 13.62M | 7.77M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 100.24M | 90.45M | 68.77M | 63.98M | 32.47M | 17.23M | 11.14M |
Operating income | -68.32M | -116.75M | -51.33M | -58.20M | -27.72M | -16.52M | -11.14M |
Other income (expenses), net | 594K | 30K | 1.42M | 2.63M | -37K | -302K | -4K |
Income before tax | -67.73M | -116.72M | -49.90M | -55.57M | -27.36M | -16.83M | -11.40M |
Income tax expense | -594K | 49.71M | -3.53M | -3.57M | 358K | 268K | 257K |
Net income | -67.13M | -166.43M | -46.37M | -51.99M | -27.36M | -16.83M | -11.40M |
Earnings per share | |||||||
Basic EPS | -20.24 | -51.57 | -18.52 | -23.91 | -11.45 | -17.81 | -1.21 |
Diluted EPS | -20.24 | -51.57 | -18.52 | -23.91 | -11.45 | -17.81 | -1.21 |
| Data source | Data source | Data source | Data source | Data source |